–
Seres Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
−3.53
FY25:
−5.76
(positive)
Change from FY21 to FY25
millions USD
FY21:
−64.5
FY22:
−246
FY23:
−195
FY24:
−125
FY25:
−101
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.7
FY22:
−238
FY23:
–
FY24:
−126
FY25:
−70.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.6
FY22:
−250
FY23:
–
FY24:
−126
FY25:
5.70
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.6
FY22:
−250
FY23:
−114
FY24:
0.14
FY25:
5.70
All amounts in millions USD